Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kasper Harpsøe

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Journal of Molecular Graphics & Modelling|July 24, 2007
Prediction of the binding mode of biarylpropylsulfonamide allosteric AMPA receptor modulators based on docking, GRID molecular interaction fields and 3D-QSAR analysisKasper Harpsøe, Tommy Liljefors, Thomas Balle
Journal of Chemical Information and Modeling|October 12, 2011
A robust force field based method for calculating conformational energies of charged drug-like moleculesJacob Poehlsgaard, Kasper Harpsøe, Flemming Steen Jørgensen, et al.
Journal of Molecular Graphics & Modelling|August 19, 2006
Identification of a putative binding site for 5-alkyl-benzothiadiazides in the AMPA receptor dimer interfaceKasper Harpsøe, Thomas Varming, Alex Haahr Gouliaev, et al.
Current Opinion in Pharmacology|August 1, 2016
Integrating structural and mutagenesis data to elucidate GPCR ligand bindingChristian Munk, Kasper Harpsøe, Alexander S Hauser, et al.
Bioinformatics (Oxford, England)|December 25, 2016
Structural insight to mutation effects uncover a common allosteric site in class C GPCRsKasper Harpsøe, Michael W Boesgaard, Christian Munk, et al.
ACS Medicinal Chemistry Letters|March 16, 2023
Introducing Conformational Restraints on 25CN-NBOH: A Selective 5-HT<sub>2A</sub> Receptor AgonistEmil Marcher-Rørsted, Jitka Nykodemová, Kasper Harpsøe, et al.
Journal of Medicinal Chemistry|March 24, 2009
Complementary three-dimensional quantitative structure-activity relationship modeling of binding affinity and functional potency: a study on alpha4beta2 nicotinic ligandsPaolo Tosco, Philip K Ahring, Tino Dyhring, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 29, 2011
Unraveling the high- and low-sensitivity agonist responses of nicotinic acetylcholine receptorsKasper Harpsøe, Philip K Ahring, Jeppe K Christensen, et al.
Neurochemical Research|February 5, 2014
mGluR5: exploration of orthosteric and allosteric ligand binding pockets and their applications to drug discoveryChristina Mølck, Kasper Harpsøe, David E Gloriam, et al.
The Journal of Biological Chemistry|January 10, 2009
Rational design of alpha-conotoxin analogues targeting alpha7 nicotinic acetylcholine receptors: improved antagonistic activity by incorporation of proline derivativesChristopher Armishaw, Anders A Jensen, Thomas Balle, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Journal of Molecular Graphics & Modelling|July 24, 2007
Prediction of the binding mode of biarylpropylsulfonamide allosteric AMPA receptor modulators based on docking, GRID molecular interaction fields and 3D-QSAR analysisKasper Harpsøe, Tommy Liljefors, Thomas Balle
Journal of Chemical Information and Modeling|October 12, 2011
A robust force field based method for calculating conformational energies of charged drug-like moleculesJacob Poehlsgaard, Kasper Harpsøe, Flemming Steen Jørgensen, et al.
Journal of Molecular Graphics & Modelling|August 19, 2006
Identification of a putative binding site for 5-alkyl-benzothiadiazides in the AMPA receptor dimer interfaceKasper Harpsøe, Thomas Varming, Alex Haahr Gouliaev, et al.
Current Opinion in Pharmacology|August 1, 2016
Integrating structural and mutagenesis data to elucidate GPCR ligand bindingChristian Munk, Kasper Harpsøe, Alexander S Hauser, et al.
Bioinformatics (Oxford, England)|December 25, 2016
Structural insight to mutation effects uncover a common allosteric site in class C GPCRsKasper Harpsøe, Michael W Boesgaard, Christian Munk, et al.
ACS Medicinal Chemistry Letters|March 16, 2023
Introducing Conformational Restraints on 25CN-NBOH: A Selective 5-HT<sub>2A</sub> Receptor AgonistEmil Marcher-Rørsted, Jitka Nykodemová, Kasper Harpsøe, et al.
Journal of Medicinal Chemistry|March 24, 2009
Complementary three-dimensional quantitative structure-activity relationship modeling of binding affinity and functional potency: a study on alpha4beta2 nicotinic ligandsPaolo Tosco, Philip K Ahring, Tino Dyhring, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 29, 2011
Unraveling the high- and low-sensitivity agonist responses of nicotinic acetylcholine receptorsKasper Harpsøe, Philip K Ahring, Jeppe K Christensen, et al.
Neurochemical Research|February 5, 2014
mGluR5: exploration of orthosteric and allosteric ligand binding pockets and their applications to drug discoveryChristina Mølck, Kasper Harpsøe, David E Gloriam, et al.
The Journal of Biological Chemistry|January 10, 2009
Rational design of alpha-conotoxin analogues targeting alpha7 nicotinic acetylcholine receptors: improved antagonistic activity by incorporation of proline derivativesChristopher Armishaw, Anders A Jensen, Thomas Balle, et al.
Pageof 5